Adicet Bio, Inc. (ACET) vs Fractyl Health, Inc. (GUTS)

A side-by-side comparison of Adicet Bio, Inc. and Fractyl Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Adicet Bio, Inc. logo
ACET
Adicet Bio, Inc.
$61M
$6.52HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Fractyl Health, Inc. logo
GUTS
Fractyl Health, Inc.
$59M
$4.48HealthcareDelayed quote: Oct 6, 2026, 11:24 AM EDT

Total return — ACET vs GUTS

growth of $100 · dividends reinvested · last 3y
ACET -86.5% (-48.7%/yr)GUTS -97.0% (-69.1%/yr)ACET compounded faster over this window
050100Start $10020252026$14$3
ACET GUTS

ACET vs GUTS: by the numbers

  • •ACET is the larger company ($61M vs $59M market cap).

Metrics side by side

Valuation

MetricACETGUTS
P/B ratio0.51N/A

Profitability

MetricACETGUTS
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-82.38%N/A
ROIC-79.68%-129.67%

Growth (annualized)

MetricACETGUTS
Total return CAGR (5Y)-44.24%N/A

Go deeper

Full ACET analysisFull GUTS analysisInteractive comparison tool

Dig into the metrics

Adicet Bio ROEFractyl Health ROEAdicet Bio operating marginFractyl Health operating marginAdicet Bio revenue growthFractyl Health revenue growthAdicet Bio free cash flowFractyl Health free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.